Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 60

1.

Anti-human immunodeficiency virus activity of a new immunosuppressant drug called stepronin.

de Giorgi L, Habeshaw JA, Broadhurst K, Carminati P, Oxford JS.

Transplant Proc. 1999 Dec;31(8):3257. No abstract available.

PMID:
10616467
2.

How HIV-1 lentivirus causes immune deficiency disease.

Habeshaw JA, Wilson SE, Hounsell EF, Oxford JS.

Med Hypotheses. 1999 Jan;52(1):59-67.

PMID:
10342673
3.
4.

Modeling HIV concentration during acute AIDS infection.

Wilson SE, Habeshaw JA, Oxford JS.

Science. 1996 Jun 28;272(5270):1960-2. No abstract available.

PMID:
8658173
5.

Absence of GVH diseases in AIDS.

Habeshaw JA, Dalgleish AG, Hounsell EF.

J Acquir Immune Defic Syndr. 1994 Dec;7(12):1287-9. No abstract available.

PMID:
7848453
6.

HLA mimicry by HIV-1 gp120 in the pathogenesis of AIDS.

Habeshaw JA.

Immunol Today. 1994 Jan;15(1):39-40. No abstract available.

PMID:
8136011
7.
8.

Role of flanking variable sequences in antigenicity of consensus regions of HIV gp120 for recognition by specific human T helper clones.

Manca F, Habeshaw JA, Dalgleish AG, Fenoglio D, Li Pira G, Sercarz EE.

Eur J Immunol. 1993 Jan;23(1):269-74.

PMID:
7678227
9.

Tolerance induction to an alloepitope involves antibodies interacting with the T cells activated by the alloepitope.

De Giorgi L, Habeshaw JA, Cazenave PA.

Res Immunol. 1992 Nov-Dec;143(9):863-71.

PMID:
1283923
10.

Inhibitory activity of HIV envelope gp120 dominates over its antigenicity for human T cells.

Manca F, Walker L, Newell A, Celada F, Habeshaw JA, Dalgleish AG.

Clin Exp Immunol. 1992 Apr;88(1):17-22.

11.

Antiidiotypic responses to immunization with anti-Leu 3a in human immunodeficiency virus-seropositive individuals.

Wilks D, Walker LC, Habeshaw JA, Webster AD, Dalgleish AG.

J Infect Dis. 1991 Feb;163(2):389-92.

PMID:
1671054
12.

AIDS pathogenesis: HIV envelope and its interaction with cell proteins.

Habeshaw JA, Dalgleish AG, Bountiff L, Newell AL, Wilks D, Walker LC, Manca F.

Immunol Today. 1990 Nov;11(11):418-25. Review.

PMID:
2078296
13.

HIV envelope glycoprotein, antigen specific T-cell responses, and soluble CD4.

Manca F, Habeshaw JA, Dalgleish AG.

Lancet. 1990 Apr 7;335(8693):811-5.

PMID:
1690832
14.

Anti-CD4 autoantibodies and screening for anti-idiotypic antibodies to anti-CD4 monoclonal antibodies in HIV-seropositive people.

Wilks D, Walker LC, Habeshaw JA, Youle M, Gazzard B, Dalgleish AG.

AIDS. 1990 Feb;4(2):113-8.

PMID:
2328093
15.

Reduction of graft-versus-host disease in neonatal F1 hybrid mice.

DeGiorgi L, Habeshaw JA, Povey S, Matossian-Rogers A.

Clin Exp Immunol. 1990 Jan;79(1):130-4.

16.

T cells in follicular centroblastic/centrocytic (cleaved follicular centre cell) lymphomas at diagnosis, relapse and transformation.

Swerdlow SH, Habeshaw JA, Murray LJ, Stansfeld AG.

Hematol Oncol. 1989 Sep-Oct;7(5):355-63.

PMID:
2670727
17.
18.

Prevention of graft-versus-host disease in neonatal F1 hybrid mice by pre-immunisation of their mother with paternal spleen cells.

DeGiorgi L, Povey S, Habeshaw JA, Davies AJ.

Transplant Proc. 1989 Feb;21(1 Pt 3):3045-9. No abstract available.

PMID:
2650421
19.

The relevance of HIV env/CD4 interactions to the pathogenesis of acquired immune deficiency syndrome.

Habeshaw JA, Dalgleish AG.

J Acquir Immune Defic Syndr. 1989;2(5):457-68. Review.

PMID:
2677311
20.

Antibody-dependent cell-mediated cytotoxicity: comparison between HTLV-I and HIV-1 assays.

Sinclair AL, Habeshaw JA, Muir L, Chandler P, Forster S, Cruickshank K, Dalgleish AG.

AIDS. 1988 Dec;2(6):465-72.

PMID:
3149493
21.
22.
23.

Angio-immunoblastic lymphadenopathy: a clinical, immunological and molecular study.

Ganesan TS, Dhaliwal HS, Dorreen MS, Stansfeld AG, Habeshaw JA, Lister TA.

Br J Cancer. 1987 Apr;55(4):437-42.

24.
25.

Are kappa and lambda light-chain-bearing B cells functionally distinct?

Swerdlow SH, Murray LJ, Habeshaw JA.

Immunol Today. 1985 Jul;6(7):200. doi: 10.1016/0167-5699(85)90030-1. No abstract available.

PMID:
25290176
27.

Two monoclonal antibodies raised against a Burkitt lymphoma cell line recognise different cell types within lymphoid follicles.

Murray LJ, Dhut S, Walker LC, Rainey M, Habeshaw JA.

Clin Exp Immunol. 1985 Feb;59(2):315-26.

28.

Two monoclonal antibodies raised against a Burkitt lymphoma cell line recognise separate components of lymphoid follicles.

Murray LJ, Habeshaw JA.

Adv Exp Med Biol. 1985;186:971-8. No abstract available.

PMID:
4050602
29.

T lymphoblastic lymphoma with LEU-7 positive phenotype and unusual clinical course: a multiparameter study.

Swerdlow SH, Habeshaw JA, Richards MA, Rainey M, Murray LJ, Stansfeld AG.

Leuk Res. 1985;9(1):167-73.

PMID:
3872971
30.

Normal values for the different classes of venous blood mononuclear cells defined by monoclonal antibodies.

Goff LK, Habeshaw JA, Rose ML, Gracie JA, Gregory W.

J Clin Pathol. 1985 Jan;38(1):54-9.

31.
32.

Caribbean T-cell lymphoma/leukemia.

Swerdlow SH, Habeshaw JA, Rohatiner AZ, Lister TA, Stansfeld AG.

Cancer. 1984 Aug 15;54(4):687-96.

PMID:
6234983
33.

Distribution of B lymphocyte subsets in normal lymphoid tissue.

Murray LJ, Swerdlow SH, Habeshaw JA.

Clin Exp Immunol. 1984 May;56(2):399-406.

34.

Characteristics of Sternberg-Reed, and related cells in Hodgkin's disease: an immunohistological study.

Dorreen MS, Habeshaw JA, Stansfeld AG, Wrigley PF, Lister TA.

Br J Cancer. 1984 Apr;49(4):465-76.

35.

Early involvement of the bronchi in patients with malignant lymphoma.

Gallagher CJ, Knowles GK, Habeshaw JA, Green M, Malpas JS, Lister TA.

Br J Cancer. 1983 Dec;48(6):777-81.

36.

Centrocytic lymphoma: a distinct clinicopathologic and immunologic entity. A multiparameter study of 18 cases at diagnosis and relapse.

Swerdlow SH, Habeshaw JA, Murray LJ, Dhaliwal HS, Lister TA, Stansfeld AG.

Am J Pathol. 1983 Nov;113(2):181-97.

37.

Correlation of transferrin receptor expression with histological class and outcome in non-Hodgkin lymphoma.

Habeshaw JA, Lister TA, Stansfeld AG, Greaves MF.

Lancet. 1983 Mar 5;1(8323):498-501.

PMID:
6131211
38.
39.

Distribution of T-lymphocyte subsets in Hodgkin's disease characterized by monoclonal antibodies.

Dorreen MS, Habeshaw JA, Wrigley PF, Lister TA.

Br J Cancer. 1982 Apr;45(4):491-9.

40.

Separation and characterization of tonsillar germinal centre lymphocytes using peanut lectin.

Rose ML, Booth RJ, Habeshaw JA, Robertson D.

Adv Exp Med Biol. 1982;149:773-80. No abstract available.

PMID:
6983240
41.

Immunoperoxidase analysis of B and T cell populations in human lymphoid follicles.

Bailey DJ, Rainey M, Habeshaw JA.

Adv Exp Med Biol. 1982;149:809-16. No abstract available.

PMID:
6756083
42.

Binding of peanut lectin to germinal-centre cells: a marker for B-cell subsets of follicular lymphoma?

Rose ML, Habeshaw JA, Kennedy R, Sloane J, Wiltshaw E, Davies AJ.

Br J Cancer. 1981 Jul;44(1):68-74.

43.

Heterogeneity of lymphoblastic malignancies in children.

Habeshaw JA.

J Cancer Res Clin Oncol. 1981;101(1):23-7.

PMID:
6974171
44.

Adenosine deaminase concentrations in leukaemia and lymphoma: relation to cell phenotypes.

Ganeshaguru K, Lee N, Llewellin P, Prentice HG, Hoffbrand AV, Catovsky D, Habeshaw JA, Robinson J, Greaves MF.

Leuk Res. 1981;5(3):215-22. No abstract available.

PMID:
6973675
45.

Immunofluorescence analysis of normal and malignant lymphoid tissues with selected combination of antisera.

Janossy G, Thomas JA, Habeshaw JA.

J Histochem Cytochem. 1980 Nov;28(11):1207-14.

PMID:
7000889
46.

Immuno-histological diagnosis of lymphoproliferative diseases by selected combinations of antisera and monoclonal antibodies.

Janossy G, Thomas JA, Pizzolo G, Granger SM, McLaughlin J, Habeshaw JA, Stansfeld AG, Sloane J.

Br J Cancer. 1980 Aug;42(2):224-42.

47.

Surface phenotyping, histology and the nature of non-Hodgkin lymphoma in 157 patients.

Habeshaw JA, Catley PF, Stansfeld AG, Brearley RL.

Br J Cancer. 1979 Jul;40(1):11-34.

48.

Spontaneous resolution of lichen myxoedematosus.

Hardie RA, Hunter JA, Urbaniak S, Habeshaw JA.

Br J Dermatol. 1979 Jun;100(6):727-30.

PMID:
88953
49.

Terminal deoxynucleotidyl transferase activity in lymphoma.

Habeshaw JA, Catley PF, Stansfield AG, Ganeshaguru K, Hoffbrand AV.

Br J Cancer. 1979 May;39(5):566-9.

50.

Rosetting and other reactions of the Reed-Sternberg cell.

Stuart AE, Williams AR, Habeshaw JA.

J Pathol. 1977 Jun;122(2):81-90.

PMID:
327044

Supplemental Content

Loading ...
Support Center